Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- The CFO of Adobe is leaving for Marvell. Additionally, it’s another reason why investors prefer chips to software.
- Following Pakistan’s announcement that a peace agreement between the United States and Iran had been struck, global oil prices end at a three-month low.
- Why value stocks are outperforming growth by such a large margin: “This is not a flash in the pan”
- “I’m not sure that this could have gone much better” is how Elon Musk executed the SpaceX IPO flawlessly.
- Is it too late to get stock in SpaceX? Here are Tesla’s results after five years and one day.
- How to determine if a large purchase, such as thousands of dollars for World Cup or Knicks tickets, is worthwhile
- FIFA World Cup prize money: What each USMNT player stands to earn
- Nike has just had its stock downgraded one day before the World Cup starts
Author: starbpo
In a $256 million deal to buy the assets of the bankrupt 23andMe Holding Co., Regeneron announced Monday that it will “prioritize the privacy, security, and ethical use” of the personal DNA data of roughly 15 million people. As required of all bids in the bankruptcy auction for 23andMe, Regeneron, a biotechnology company based in Westchester, New York, promised to collaborate with an impartial, court-appointed customer-privacy ombudsman to safeguard clients. After the deal closes as anticipated in the third quarter of this year, Regeneron stated that it will continue to provide 23andMe’s consumer genome services, including the ability to connect…
After a protracted regulatory approval procedure, Capital One Financial Corp. stated on Sunday that it has successfully finalized the acquisition of Discover Financial Services. The merger agreement was announced in February 2024. As investors were more optimistic that the acquisition would be finalized, Discover shares had returned 16% and Capital One’s (COF) stock had returned 10.9% through Friday for 2025. So far this year, the KBW Bank Index has returned 2.8%. Reinvested dividends are included in those numbers. Investors may be questioning if Capital One’s postmerger valuation has reached its full potential. Sanjay Sakhrani, an analyst at Keefe, Bruyette &…
levies between the United States and China were both significantly reduced about a month after “Liberation Day” and the massive levies that were declared on that day. Later, more on that. Sean Simonds, the strategist at UBS, has sent out a timely note stating that the questioning will now concentrate more on result uncertainty and less on policy uncertainty. “We are possibly past the peak of uncertainty as more granular detail on tariffs and other policies come into focus,” they claim. As the writers chose, “What comes after this, however, is the policy OUTCOME uncertainty,” is capitalized. Given sector tariffs…
Financial markets might finally get what they want, at least for the time being, after months of a simmering tariff war that was mostly centered on the United States and China. After representatives from the Trump administration and China revealed plans on Monday to simultaneously reduce each other’s tariffs in an effort to ease simmering tensions, officials may have bought some market patience. “We have reached an agreement on a 90-day pause and substantially moved down the tariff levels,” Treasury Secretary Scott Bessent stated at a press conference in Geneva on Monday after meeting with Chinese officials over the weekend.…
According to a research comparing two popular weight-loss medications, users of Zepbound from Eli Lilly dropped somewhat more than 2 inches off their waist than those who took Wegovy, a competitor product from Novo Nordisk. According to findings presented at the European Congress on Obesity and published in the New England Journal of Medicine, individuals utilizing Zepbound experienced an average weight-loss decrease of 20.2% at 72 weeks, compared to 13.7% with Novo Nordisk’s own medication, according to Eli Lilly. In December, Eli Lilly revealed the preliminary results of the trial. According to Eli Lilly, Zebound achieved its primary target and…
President Donald Trump’s announcement that he will sign an executive order to lower prescription drug prices put pressure on pharmaceutical companies’ stock before Monday’s opening. Trump stated in a post on his Truth Social platform on Sunday that the order, which is scheduled to be signed at 9 a.m. on Monday, will establish a “most favored nation” program in which the United States will pay the same amount for pharmaceuticals and prescription medications “as the nation that pays the lowest price anywhere in the world.” According to Trump, his decision will “almost immediately” lower the cost of pharmaceuticals and prescription…
At the very least, Costco Wholesale Corp. (COST) was able to increase sales in April when President Donald Trump intensified his trade battle. Mattel Inc. (MAT) temporarily ceased attempting to predict the impacts of tariffs, while Amazon.com Inc. (AMZN) stated that it has not yet experienced any impact. Restaurants have reported that imports are beginning to decline and that customers are becoming more wary. However, when big-box retailer and online retailer Walmart Inc. (WMT) releases its first-quarter earnings on Thursday, we’ll get the clearest glimpse yet of how consumers are doing. Walmart released its report Thursday, which analyst Michael Baker…
Since plummeting to an intra-session low on April 7, S&P 500 futures have increased by around 18%. They will be recording a bull market once more after a few more good days. It is evident that traders believe the stock market overreacted to the possible harm that the Trump trade war could wreak a month ago. In that sense, Trump’s 90-day halt to his “reciprocal” tariff plan was quite beneficial. Goldman Sachs, meanwhile, is still worried. Alec Phillips, the chief political economist at the bank, recently issued a warning, stating that the U.S. President’s remarks on the trade agreement with…
With his new plans to increase taxes on Wall Street and Silicon Valley investors as well as rich Americans, President Donald Trump has the potential to upend decades of Republican tax dogma. In addition to removing the so-called carried-interest loophole that enriches alternative-asset managers, the president is pressuring congressional Republicans to enact new tax increases on workers earning over $2.5 million annually and households earning over $5 million annually. According to someone acquainted with Trump’s thinking, he views this as a means of avoiding Medicaid cuts and financing reduced taxes for middle-class and working-class Americans. Trump stated on Thursday’s Truth…
According to a risk-on/risk-off metric that tracks investor sentiment and was developed by analytics firm Duality Research, risk aversion ruled for the majority of last month. However, in May, the mood shifted to one that is more enthusiastic. Duality clarified in an interview with MarketWatch that its metric is based on several input variables, the most significant of which looks at the relative strength of defensive stocks. “Ultimately, we’re aiming to gain a more comprehensive perspective on defensive names and how they’re performing relative to the broader market,” stated Duality. Investors are frequently expressing a desire to place riskier wagers…
BourseWatch
Recent Post
-
The CFO of Adobe is leaving for Marvell. Additionally, it's another reason why investors prefer chips to software. -
Following Pakistan's announcement that a peace agreement between the United States and Iran had been struck, global oil prices end at a three-month low. -
Why value stocks are outperforming growth by such a large margin: "This is not a flash in the pan"
Subscribe to Updates
Get the latest creative news from BourseWatch
